Clinical Trial Update: Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer

View source ↗

Summary

A completed clinical trial evaluated anti-IMP3 autoantibody and microRNA signature blood tests for detecting metastasis in patients with localized or metastatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: City of Hope Medical Center | Conditions: Kidney Cancer | Status: COMPLETED